But is someone partners on fibrosis, what prevents the partner from having access to the treatment in a dancer indication. They could prescribe it to treat the fibrosis component. (Realuzung it's not approved , yet.
I also thought some about a drug I looked up recently.
Bria Cell. (Maybe it's the company name or both).
I looked it up after another poster different board stated an effect of the drug was raising pdl1 etc.
I'm sure there are reasons I don't know but here is their branding.
Key BriaCell Treatment Names and Variants:
-Bria-IMT™: The lead candidate, a cell therapy for advanced breast cancer.
-Bria-OTS™/Bria-OTS+™: A personalized, HLA-matched, off-the-shelf immunotherapy.
-Bria-PROS™/Bria-PROS+™: Specifically for prostate cancer.
-Bria-Lung™/Bria-LUNG+™: Targeted for lung cancer.
-Bria-Mel™/Bria-MEL+™: Targeted for melanoma.
-Bria-BRES™/Bria-BRES+™: A variant specifically in study for breast cancer.
I wonder if cydy is considering anything like this or too late?
I did notice creatv bio had a recent poster for bria cell .
(One of the only 2 I think posters creatv has done that is not funded by a dept defense entity if anyone finds that meaningful)
I checked out the poster to check in the pdl1 thing.
Someone else could better analyze it than me. But it appears bria cell raised pdl1. Ici started working. Ici levels later dropped. Disease progression - new mestasis.
Here is the poster if anyone interested. Maybe some info here for someone more knowledgeable than ne.
Monitoring Upregulation of PD-L1 in Cancer Associated Macrophage-Like Cells in Blood Predicts Clinical Outcomes in Metastatic Cancer Patients Treated with PD-L1 Immunotherapies
https://creatvbio.com/s/Adams_SABCS-PDL1-upre...breast.pdf